Mandag, Lita B.

HRN: 12-11-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2024
CO-AMOXICLAV 625MG (TAB)
01/28/2024
02/04/2024
ORAL
625mg
BID
BLEPHARITIS
Waiting Final Action 
01/30/2024
CLARITHROMYCIN 500MG (CAP)
01/30/2024
02/06/2024
ORAL
500mg
BID
H. PYLORI INFECTION
Waiting Final Action 
01/30/2024
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
01/30/2024
02/06/2024
TOPICAL
Sufficient Amount
BID
Blepharitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: